Literature DB >> 22466549

Effect of lipopolysaccharide on the xenobiotic-induced expression and activity of hepatic cytochrome P450 in mice.

Nozomu Moriya1, Hiromi Kataoka, Hideki Fujino, Jun-ichi Nishikawa, Fumihiko Kugawa.   

Abstract

Infection-associated inflammation can alter the expression levels and functions of cytochrome P450s (CYPs). Cyp gene expression is regulated by the activation of several nuclear receptors, including pregnane X receptor (PXR), constitutive androstane receptor (CAR), and aryl hydrocarbon receptor (AhR). These receptors can be activated by xenobiotics, including medicines. Here, to study the xenobiotic-induced fluctuations in CYP during inflammation, we examined the effect of lipopolysaccharide (LPS) treatment on the level of mRNAs encoding hepatic CYPs induced by xenobiotic-activated nuclear receptors, in mice. Both the mRNA induction of Cyp genes and the metabolic activities of CYP proteins were examined. LPS treatment caused a significant decrease in the induced expression of the mRNAs for Cyp3a11, 2c29, 2c55, and 1a2, but not for Cyp2b10. To assess the CYP enzymatic activities, CYP3A-mediated testosterone 6β-hydroxylation and the intrinsic clearance (CL(int)) of nifedipine in liver microsomes were measured in mice treated with the xenobiotic pregnenolone-16alpha-carbonitrile (PCN) with or without LPS administration. Both assays revealed that the CYP3A activity, which was induced by PCN, declined significantly after LPS treatment, and this decline correlated with the Cyp3a11 mRNA level. In addition, we found that the mRNAs for interleukin (IL)-1β and tumor necrosis factor (TNF) α were increased after treatment with LPS plus xenobiotics. Our findings demonstrated that LPS treatment reduces the PXR- and AhR-mediated, and possibly CAR-mediated Cyp gene expression and further suggest that these decreases are dependent on inflammatory cytokines in the liver.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22466549     DOI: 10.1248/bpb.35.473

Source DB:  PubMed          Journal:  Biol Pharm Bull        ISSN: 0918-6158            Impact factor:   2.233


  15 in total

Review 1.  Eicosanoids in metabolic syndrome.

Authors:  James P Hardwick; Katie Eckman; Yoon Kwang Lee; Mohamed A Abdelmegeed; Andrew Esterle; William M Chilian; John Y Chiang; Byoung-Joon Song
Journal:  Adv Pharmacol       Date:  2013

Review 2.  Regulation of drug-metabolizing enzymes by local and systemic liver injuries.

Authors:  Yan Guo; Bingfang Hu; Yang Xie; Timothy R Billiar; Jason L Sperry; Min Huang; Wen Xie
Journal:  Expert Opin Drug Metab Toxicol       Date:  2016-01-28       Impact factor: 4.481

3.  PXR mediates mifepristone-induced hepatomegaly in mice.

Authors:  Xin-Peng Yao; Ting-Ying Jiao; Yi-Ming Jiang; Shi-Cheng Fan; Ying-Yuan Zhao; Xiao Yang; Yue Gao; Fei Li; Yan-Ying Zhou; Pan-Pan Chen; Min Huang; Hui-Chang Bi
Journal:  Acta Pharmacol Sin       Date:  2021-03-29       Impact factor: 6.150

4.  Pharmacokinetics of Morphine in Rats with Adjuvant-induced Arthritis.

Authors:  Yoshiaki Kimura; Mika Shibata; Mika Tamada; Noriyuki Ozaki; Kunizo Arai
Journal:  In Vivo       Date:  2017 Sep-Oct       Impact factor: 2.155

5.  Alcohol cirrhosis alters nuclear receptor and drug transporter expression in human liver.

Authors:  Vijay R More; Qiuqiong Cheng; Ajay C Donepudi; David B Buckley; Zhenqiang James Lu; Nathan J Cherrington; Angela L Slitt
Journal:  Drug Metab Dispos       Date:  2013-03-05       Impact factor: 3.922

Review 6.  Involvement of cytochrome P450 enzymes in inflammation and cancer: a review.

Authors:  Maria Carolina Stipp; Alexandra Acco
Journal:  Cancer Chemother Pharmacol       Date:  2020-10-28       Impact factor: 3.333

7.  Expression of Cyp2c/Cyp2j subfamily members and oxylipin levels during LPS-induced inflammation and resolution in mice.

Authors:  Joan P Graves; J Alyce Bradbury; Artiom Gruzdev; Hong Li; Caroline Duval; Fred B Lih; Matthew L Edin; Darryl C Zeldin
Journal:  FASEB J       Date:  2019-11-05       Impact factor: 5.834

8.  Pharmacogenomic characterization of gemcitabine response--a framework for data integration to enable personalized medicine.

Authors:  Michael Harris; Krithika Bhuvaneshwar; Thanemozhi Natarajan; Laura Sheahan; Difei Wang; Mahlet G Tadesse; Ira Shoulson; Ross Filice; Kenneth Steadman; Michael J Pishvaian; Subha Madhavan; John Deeken
Journal:  Pharmacogenet Genomics       Date:  2014-02       Impact factor: 2.089

9.  The Impact of MicroRNA-223-3p on IL-17 Receptor D Expression in Synovial Cells.

Authors:  Nozomu Moriya; Seiji Shibasaki; Miki Karasaki; Tsuyoshi Iwasaki
Journal:  PLoS One       Date:  2017-01-05       Impact factor: 3.240

10.  Pulmonary Inflammation Impacts on CYP1A1-Mediated Respiratory Tract DNA Damage Induced by the Carcinogenic Air Pollutant Benzo[a]pyrene.

Authors:  Volker M Arlt; Annette M Krais; Roger W Godschalk; Yanira Riffo-Vasquez; Iveta Mrizova; Candice A Roufosse; Charmaine Corbin; Quan Shi; Eva Frei; Marie Stiborova; Frederik-Jan van Schooten; David H Phillips; Domenico Spina
Journal:  Toxicol Sci       Date:  2015-04-23       Impact factor: 4.849

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.